On Invalid Date, Solid Biosciences (NASDAQ: SLDB) reported Q4 2023 earnings per share (EPS) of -$1.00, up 47.06% year over year. Total Solid Biosciences earnings for the quarter were -$20.34 million. In the same quarter last year, Solid Biosciences's earnings per share (EPS) was -$0.68.
As of Q1 2024, Solid Biosciences's earnings has grown year over year. Solid Biosciences's earnings in the past year totalled -$96.02 million.
What is SLDB's earnings date?
Solid Biosciences's earnings date is Invalid Date. Add SLDB to your watchlist to be reminded of SLDB's next earnings announcement.
What was SLDB's revenue last quarter?
On Invalid Date, Solid Biosciences (NASDAQ: SLDB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Solid Biosciences's revenue was $0.00.
What was SLDB's revenue growth in the past year?
As of Q1 2024, Solid Biosciences's revenue has grown -100% year over year. This is 265.61 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Solid Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.